Neglected tropical diseases: Infection, modeling, and control

Journal of Health Care for the Poor and Underserved

Volumn 21, Issue 1, 2010, Pages 53-69

  Kealey, Alison ^a   Smith, Robert ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Chagas' disease; Dracunculiasis; Leishmaniasis; Leprosy; Lymphatic filariasis; Mathematical models; Neglected tropical diseases; Onchocerciasis; Schistosomiasis; Sleeping sickness; Soil transmitted helminthiasis; The Buruli ulcer; Trachoma

Indexed keywords

ANIMAL; BACTERIAL INFECTION; BIOLOGICAL MODEL; HEALTH; HELMINTHIASIS; HUMAN; INFECTION CONTROL; METHODOLOGY; POVERTY; PROTOZOAL INFECTION; REVIEW; RISK FACTOR; TROPICAL MEDICINE;

ANIMALS; BACTERIAL INFECTIONS; COMMUNICABLE DISEASE CONTROL; HELMINTHIASIS; HUMANS; MODELS, BIOLOGICAL; POVERTY AREAS; PROTOZOAN INFECTIONS; RISK FACTORS; TROPICAL MEDICINE; WORLD HEALTH;

EID: 72849146247     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: 10.1353/hpu.0.0270     Document Type: Review

References (83)

1. Engels D, Savioli L. Reconsidering the underestimated burden caused by neglected tropical diseases. Trends Parasitol. 2006 Aug;22(8):363-366 Epub 2006 Jun 23.
2. Hotez PJ, Molyneux DH, Fenwick A, et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 2006 Jan;3(5):e102.
3. Kindhauser MK. Communicable diseases 2002: global defence against the infectious disease threat. Geneva, Switzerland: World Health Organization, 2003.
4. Molyneux DH. "Neglected" diseases but unrecognised successes-challenges and opportunities for infectious disease control. Lancet. 2004 Jul 24-30;364(9431):380-383
5. Hotez PJ, Ottesen E, Fenwick A, et al. The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination. In: Pollard AJ, Finn A, eds. Hot topics in infection and immunity in children III. New York: Kluwer Academic/Plenum Publishers, 2006.
6. Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med. 2007 Sep 6;357(10):1018-1027
7. Department of Control of Neglected Tropical Diseases. Neglected tropical diseases: hidden successes, emerging opportunities. Geneva, Switzerland: World Health Organization, 2006.
8. Morel CM. Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality? EMBO Rep. 2003 Jun;4 Spec No:S35-8.
9. World Health Organization. Global plan to combat neglected tropical diseases 2008-2015. Geneva, Switzerland: World Health Organization, 2007. Available at: http://whqlibdoc.who.int/hq/2007/WHO-CDS-NTD-2007.3-eng.pdf.
10. Heymann DL. Control of communicable diseases manual (18th ed.). Washington, DC: American Public Health Association, 2004.
11. World Health Organization. Chagas disease (American trypanosomiasis). Geneva, Switzerland: World Health Organization, 2008. Available at: http://www.who.int/neglected-diseases/diseases/chagas/en/index.html.
12. World Health Organization. Priority eye diseases: trachoma. Geneva, Switzerland: World Health Organization, 2008. Available at: http://www.who.int/ blindness/causes/ priority/en/index2.html.
13. Canning D. Priority setting and the 'neglected' tropical diseases. Trans R Soc Trop Med Hyg. 2006 Jun;100(6):499-504. Epub 2006 Mar 15.
14. Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ. 1997 Dec;16:685-702.
15. King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005 Apr 30-May 6;365(9470):1561-1569
16. Brauer F. Mathematical epidemiology is not an oxymoron. BMC Public Health. 2009;9(Suppl 1):S2.
17. Heffernan JM, Smith RJ, Wahl LM. Perspectives on the basic reproductive ratio. J R Soc Interface. 2005 Sep 22;2(4):281-293
18. Ruiz-Tiben E, Hopkins DR. Dracunculiasis (Guinea worm disease) eradication. Adv Parasitol. 2006;61:275-309. (Pubitemid 44226345)
19. Dye C. The logic of visceral leishmaniasis control. Am J Trop Med Hyg. 1996 Aug; 55(2):125-130
20. Chaves LF, Hernandez MJ. Mathematical modeling of American cutaneous leishmaniasis: incidental hosts and threshold conditions for infection persistence. Acta Trop. 2004 Nov-Dec;92(3):245-252
21. De Almeida MC, Moreira HN. A mathematical model of immune response in cutaneous leishmania. Journal of Biological Systems. 2007;15(3):313-354
22. Baker RD. Modeling trypanosomiasis prevalence and periodic epidemics and epizootics. Mathematical Medicine and Biology. 1992;9(4):269-287
23. Rogers DJ. A general model for the African trypanosomiases. Parasitology. 1988 Aug; 97(Pt 1):193-212.
24. Agur Z, Abiri D, Van der Ploeg LH. Ordered appearance of antigenic variants of African trypanosomes explained in a mathematical model based on a stochastic switch process and immune-selection against putative switch intermediates. Proc Natl Acad Sci USA. 1989 Dec;86(23):9626-9630
25. Artzrouni M, Gouteux JP. A compartmental model of sleeping sickness in central Africa. Journal of Biological Systems. 1996;4(4):459-477
26. Chalvet-Monfray K, Artzrouni M, Gouteux JP, et al. A two-patch model of Gambian sleeping sickness: application to vector control strategies in a village and plantations. Acta Biotheor. 1998;46(3):207-222
27. Frank SA. A model for the sequential dominance of antigenic variants in African trypanosome infections. Proc Biol Sci. 1999 Jul 7;266(1426):1397-1401
28. Muller G, Grébaut P, Gouteux JP. An agent-based model of sleeping sickness: simulation trials of a forest focus in southern Cameroon. C R Biol. 2004 Jan;327(1):1-11.
29. Cohen JE, Gürtler RE. Modeling household transmission of American trypanosomiasis. Science. 2001 Jul 27;293(5530):694-698 Epub 2001 Jul 23.
30. Peterson AT, Sánchez-Cordero V, Beard CB, et al. Ecologic niche modeling and potential reservoirs for Chagas disease, Mexico. Emerg Infect Dis. 2002 Jul;8(7):662-667
31. Inaba H, Sekine H. A mathematical model for Chagas disease with infection-agedependent infectivity. Math Biosci. 2004 Jul;190(1):39-69.
32. Chan MS, Guyatt HL, Bundy DA, et al. Dynamic models of schistosomiasis morbidity. Am J Trop Med Hyg. 1996 Jul;55(1):52-62.
33. Chan MS, Isham VS. A stochastic model of schistosomiasis immuno-epidemiology. Math Biosci. 1998 Aug 1;151(2):179-198
34. Feng Z, Li CC, Milner FA. Schistosomiasis models with density dependence and age of infection in snail dynamics. Math Biosci. 2002 May-Jun;177-178:271- 286
35. Williams GM, Sleigh AC, Li Y, et al. Mathematical modeling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China. Acta Trop. 2002 May;82(2):253-262
36. Hayashi S. A model for the evaluation and assessment of the effect of control of the soil-transmitted helminthiasis. In: Asian Parasite Control Organization [APCO]. Collected papers on the control of soil-transmitted helminthiases; Vol 1. Tokyo, Japan: Asian Parasite Control Organization, 1980; 265-273
37. Salazar NP, Montalban CS, Bustos DG, et al. A model for control of soil-transmitted helminthiasis. Phil J Microbiol Infect Dis. 1987;16(2):65-72.
38. Crompton DW, Whitehead RR. Hookworm infections and human iron metabolism. Parasitology. 1993;107 Suppl:S137-45.
39. Churcher TS, Ferguson NM, Basanez MG. Density dependence and overdispersion in the transmission of helminth parasites. Parasitology. 2005 Jul;131(Pt 1):121-132
40. Grenfell BT, Das PK, Rajagopalan PK, et al. Frequency distribution of lymphatic filariasis microfilariae in human populations: population processes and statistical estimation. Parasitology. 1990 Dec;101 Pt 3:417-427
41. Chan MS, Srividya A, Norman RA, et al. Epifil: a dynamic model of infection and disease in lymphatic filariasis. Am J Trop Med Hyg. 1998 Oct;59(4):606-614
42. Norman RA, Chan MS, Srivigya A, et al. EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect. 2000 Jun;124(3):529-541
43. Michael E, Malecela-Lazaro MN, Maegga BT, et al. Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions. Trends Parasitol. 2006 Nov;22(11):529-535 Epub 2006 Sep 12. (Pubitemid 44472617)
44. Basáñez MG, Boussinesq M. Population biology of human onchocerciasis. Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):809-826
45. Alley WS, van Oortmarssen GJ, Boatin BA, et al. Macrofilaricides and onchocerciasis control, mathematical modeling of the prospects for elimination. BMC Public Health. 2001;1:12. Epub 2001 Nov 6.
46. Filipe JA, Boussinesq M, Renz A, et al. Human infection patterns and heterogeneous exposure in river blindness. Proc Natl Acad Sci USA. 2005 Oct 18;102(42):15265-15270 Epub 2005 Oct 10.
47. Poolman EM, Galvani AP. Modeling targeted invermectin treatment for controlling river blindness. Am J Trop Med Hyg. 2006 Nov;75(5):921-927
48. Lietman T, Porco T, Blower S. Leprosy and tuberculosis: the epidemiological consequences of cross-immunity. Am J Public Health. 1997 Dec;87(12):1923-1927
49. Meima A, Gupte MD, van Oortmarssen GJ, et al. SIMLEP: a simulation model for leprosy transmission and control. Int J Lepr Other Mycobact Dis. 1999 Sep;67(3): 215-236
50. Meima A, Smith CS, van Oortmarssen GJ, et al. The future incidence of leprosy: a scenario analysis. Bull World Health Organ. 2004 May;82(5):373-380
51. Abubakar UY. A stochastic model in discrete states and discrete time for the control of leprosy disease. Leonardo Journal of Sciences. 2007;11:51-60.
52. Lietman T, Porco T, Dawson C, et al. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med. 1999 May;5(5):572-576
53. Ray KJ, Porco TC, Hong KC, et al. A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis. 2007 Aug 7;7:91.
54. Smith RJ, Blower SM. Could disease-modifying HIV vaccines cause population-level perversity? Lancet Infect Dis. 2004 Oct;4(10):636-639
55. Okell LC, Drakeley CJ, Bousema T, et al. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med. 2008 Nov 25;5(11):e226.
56. Boni MF, Buckee CO, White NJ. Mathematical models for a new era of malaria eradication. PLoS Med. 2008 Nov 25;5(11):e231.
57. McKenzie FE, Samba EM. The role of mathematical modeling in evidence-based malaria control. Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):94-96
58. Habbema JD, Alley ES, Plaisier AP, et al. Epidemiological modelling for onchocerciasis control. Parasitol Today. 1992 Mar;8(3):99-103.
59. Guillet P, Seketeli A, Alley ES, et al. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea. Bull World Health Organ. 1995;73(2):199-205.
60. Dadzie Y, Neira M, Hopkins D. Final report of the Conference on the eradicability of Onchocerciasis. Filaria J. 2003 Feb 7;2(1):2.
61. Nagelkerke NJ, Jha P, de Vlas SJ, et al. Modeling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ. 2002;80(2):89-96.
62. World Health Organization. Climate change and human health-risk and responses. Geneva, Switzerland: World Health Organization, 2009. Available at: http://www.who.int/globalchange/climate/en/chapter6.pdf.
63. Hales S, de Wet N, Maindonald J, et al. Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet. 2002 Sep 14;360(9336):830-834
64. World Health Organization. The case for completing polio eradication. Geneva, Switzerland: World Health Organization, 2008. Available at: http://www.polioeradication.org/content/publications/thecase-final.pdf.
65. Thompson KM, Tebbens RJ. Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007 Apr 21;369(9570):1363-1371
66. Kruijshaar ME, Barendregt JJ, Hoeymans N. The use of models in the estimation of disease epidemiology. Bull World Health Organ. 2002;80(8):622-628 Epub 2002 Aug 27.
67. Dasbach EJ, Elbasha EH, Insinga RP. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. Epidemiol Rev. 2006;28:88-100. Epub 2006 Jun 1.
68. Stover J. Influence of mathematical modeling of HIV and AIDS on policies and programs in the developing world. Sex Transm Dis. 2000 Nov;27(10):572-578
69. Rosenfeld LA, Fox CE, Kerr D, et al. Use of computer modeling for emergency preparedness functions by local and state health officials: a needs assessment. J Public Health Manag Pract. 2009 Mar-Apr;15(2):96-104.
70. Glasser J, Meltzer M, Levin B. Mathematical modeling and public policy: responding to health crises. Emerg Infect Dis. 2004 Nov;10(11):2050-2051
71. Smith T, Maire N, Ross A, et al. Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology. 2008 Nov;135(13):1507-1516 Epub 2008 Aug 11.
72. Taylor N. Review of the use of models in informing disease control policy development and adjustment. A report for DEFRA. Reading, UK: Use of Models in Disease Control Policy.doc, 2003. Available at: http://farmtalking.com/pdf/ science-use-of-models-in-disease-control-policy.pdf.
73. Viladent C, van Ackere A. HIV/AIDS modeling, a two-angle-retrospective. Toward a generic deterministic model for pattern II countries? Switzerland: University of Lausanne, 2007. Available at: http://www.hec.unil.ch/irm/Research/ WP0714.pdf.
74. Stover J, Willson K. Modeling the impact of AIDS vaccines: a review of the literature. New York: International AIDS Vaccine Initiative, 2005. Available at: http://www.iavi.org/file.cfm?fid=35124.
75. Rowley J. Methodologies for modeling the impact of a preventive AIDS vaccine in developing countries: recent studies. New York: International AIDS Vaccine Initiative, 2005. Available at: http://www.iavi.org/Lists/ IAVIPublications/attachments/7a82da83-d205-40cf-bed0-02958fdbe788/ IAVI-Methodologies-for-Modeling-the-Impact-of-a-Preventive-AIDS-Vaccine-in- Developing-Countrie-Recent-Studies-2005-ENG.pdf.
76. Wilson DP, Kahn J, Blower SM. Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide. Proc Natl Acad Sci USA. 2006 Sep 19;103(38):14228-14233 Epub 2006 Sep 12.
77. Killeen GF, Smith TA, Ferguson HM, et al. Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. PLoS Med. 2007 Jul;4(7):e229.
78. Blower SM, Chou T. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat Med. 2004 Oct;10(10):1111-1116 Epub 2004 Sep 19.
79. Smith RJ, Hove-Musekwa SD. Determining effective spraying periods to control malaria via indoor residual spraying in Sub-Saharan Africa. Journal of Applied Mathematics and Decision Sciences. 2008;Article ID:745463.
80. Jamison D, Breman J, Measham A, et al. Disease control priorities in developing countries (2nd ed.). New York: Oxford University Press, 2006.
81. Herber O, Kroeger A. Pyrethroid-impregnated curtains for Chagas' disease control in Venezuela. Acta Trop. 2003 Sep;88(1):33-38 (Pubitemid 37013333)
82. Trouilller P, Olliaro P, Torreele E, et al. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet. 2002 Jun 22;359(9324): 2188-2194
83. Molyneux DH, Hotez PJ, Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Medicine. 2005;2(11):e336.